Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of "Reduce" by Brokerages

Key Points

• Phibro Animal Health Corporation (NASDAQ:PAHC) has an average rating of "Reduce" from six brokerages, with two sell ratings, three hold ratings, and one buy rating.
• The company's stock opened at $37.07 and has a market cap of $1.50 billion, with a 52-week range between $16.16 and $38.83.
• Phibro recently announced a quarterly dividend of $0.12 per share, representing an annual yield of 1.3%, with a dividend payout ratio of 61.54%.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) has earned an average rating of "Reduce" from the six brokerages that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $28.40.

A number of brokerages have recently weighed in on PAHC. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Bank of America raised their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a report on Friday. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a report on Thursday. Finally, BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a report on Monday, June 16th.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $37.07 on Friday. The firm has a market cap of $1.50 billion, a PE ratio of 31.42, a price-to-earnings-growth ratio of 0.56 and a beta of 0.80. Phibro Animal Health has a 52-week low of $16.16 and a 52-week high of $38.83. The company has a quick ratio of 1.23, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. The company's 50 day moving average is $29.34 and its two-hundred day moving average is $24.45.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.05. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The company had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, research analysts expect that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of PAHC. Envestnet Asset Management Inc. purchased a new position in shares of Phibro Animal Health in the 4th quarter valued at $219,000. Raymond James Financial Inc. purchased a new position in shares of Phibro Animal Health in the 4th quarter valued at $1,103,000. State of Tennessee Department of Treasury grew its position in shares of Phibro Animal Health by 19.3% in the 4th quarter. State of Tennessee Department of Treasury now owns 19,523 shares of the company's stock valued at $410,000 after buying an additional 3,153 shares during the last quarter. Hsbc Holdings PLC grew its position in shares of Phibro Animal Health by 53.5% in the 4th quarter. Hsbc Holdings PLC now owns 17,709 shares of the company's stock valued at $372,000 after buying an additional 6,169 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Phibro Animal Health by 9.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 17,668 shares of the company's stock valued at $372,000 after buying an additional 1,565 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.